Please login to the form below

Not currently logged in
Email:
Password:

Draftfcb New York announces internal re-shuffle

Dana Maiman to focus on Draftfcb Healthcare as agency steps up its healthcare offering

Dana Maiman, CEO and president of the Draftfcb Healthcare group of companies, who has also served as president of the New York general agency since 2010, will now focus solely on the company's healthcare business.

Debra Coughlin, global CMO of Draftfcb, has been appointed to lead the New York office on an interim basis as acting managing director while a search for the post is underway.

Laurence Boschetto, CEO and president of Draftfcb, said the move will enable Maiman's full attention on Draftfcb Healthcare, which is part of Interpublic Group.

Boschetto said: “Dana's leadership of the Draftfcb Healthcare portfolio has been inspiring to witness. The company has grown tremendously over the past decade, both in size and in creative reputation. With Dana now focusing 100 per cent on healthcare, that upward trajectory is assured.”

Draftfcb Healthcare, which in September acquired Hudson Global, a New York-based pharmaceutical marketing company to augment its medical education and integrated technology offering, is now set to form an alliance with the Argon Network, a coalition of 22 healthcare agencies spanning Europe, Asia, the Middle East and South America. The alliance is designed to provide clients with a global network solution for their brands.

29th January 2013

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics